Edesa Biotech Announces Proposed Public Offering
Edesa Biotech announced the commencement of an underwritten public offering of common shares and accompanying common share warrants. Guggenheim Securities is acting as the sole book-running manager and has been granted a 30-day option to purchase up to 15% additional shares.
Key figures
- Greenshoe percent
- 15%
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.